The Global Myocardial Infarction Therapeutics Market is estimated to be valued at USD 15.56 billion in 2023 and is projected to grow at a CAGR of 4.19% over the forecast period 2024-2032. Read the ...
The following is a summary of “Role of Inflammation in Early Left Ventricular Thrombus Formation Following ST-Elevation Myocardial Infarction—A Matched Case-Control Study,” published in the October ...
Kaare Harald Bønaa, MD, PhD, specialist in internal medicine and cardiology, senior consultant in interventional cardiology, professor emeritus in cardiovascular epidemiology and clinical director at ...
In this edition of the Journal of the Norwegian Medical Association, Bønaa et al. present the developments in the incidence of acute myocardial infarction in Norway in the period 2013–2021 (1). The ...